Retina Specialty Institute

Summary

Retina Specialty Institute is a medical facility located in Pensacola, Florida. This center is recognized for care of Macular Degeneration, Age-Related Macular Degeneration, Diabetic Macular Edema, Retinal Disease, None and other specialties. Retina Specialty Institute is involved with conducting 52 clinical trials across 22 conditions. There are 1 research doctors associated with this hospital, such as Sunil Gupta, M.D..

Top PIs

Clinical Trials running at Retina Specialty Institute

Age-Related Macular Degeneration

Macular Degeneration

Choroidal Neovascularization

Retinal Degeneration

Retinal Disease

None

Choroidal neovascularization

Wet AMD

Diabetic Macular Edema

RGX-314 Gene Therapy

for Age-Related Macular Degeneration

This trial is testing a new one-time gene therapy called RGX-314 for patients with wet AMD. The goal is to reduce the need for regular treatments by helping the eye produce its own protective proteins. This could make treatment easier and more effective for patients.

Recruiting

2 awards

Phase 3

2 criteria

4D-150 + EYLEA

for Age-Related Macular Degeneration

A Phase 3, Randomized, Double-Masked, Active-Controlled Trial in Adults with Macular Neovascularization Secondary to Age-Related Macular Degeneration

Recruiting

2 awards

Phase 3

4 criteria

PDS Implant with Ranibizumab

for Age-Related Macular Degeneration

This study will evaluate the long-term safety and tolerability of the Port Delivery System with ranibizumab (PDS) (100 mg/mL) in participants with neovascular age-related macular degeneration (nAMD) who have either completed Phase II Study GX28228 (Ladder), Phase III Study GR40548 (Archway), Phase IIIb Study WR42221 (Velodrome), or completed Week 24 visit in Study WR42221 but were not eligible to be randomized in WR42221.

Recruiting

2 awards

Phase 3

3 criteria